Source: FDA, National Drug Code (US) Revision Year: 2024
TRYVIO (aprocitentan) is an ERA. The chemical name of aprocitentan is N-[5-(4-bromophenyl)6[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide. It has a molecular formula of C16H14Br2N6O4S and a molecular weight of 546.2 g/mol.
The structural formula is:
Aprocitentan is a white to off-white powder that is insoluble in water.
TRYVIO is available as film-coated 12.5 mg strength tablets for oral administration. The inactive ingredients in TRYVIO are croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, and microcrystalline cellulose.
The film coating contains the following inactive ingredients: hydroxypropyl cellulose, iron oxide black, iron oxide red, iron oxide yellow, polyvinyl alcohol, silica colloidal hydrated, talc, titanium dioxide, and triethyl citrate.
| Dosage Forms and Strengths |
|---|
|
TRYVIO (aprocitentan) tablets are available as:
|
| How Supplied |
|---|
|
TRYVIO tablets are available as: 12.5 mg: yellow to orange round, film-coated tablet, debossed with “AN” on one side and plain on the other side.
Distributed by: Idorsia Pharmaceuticals US Inc., One Radnor Corporate Center, Suite 101, 100 Matsonford Rd., Radnor, PA 19087 |
| Drug | Countries | |
|---|---|---|
| TRYVIO | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
